Skip to main navigation Skip to search Skip to main content

COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2

  • Yasmin Hisham
  • , Sun Min Seo
  • , Sinae Kim
  • , Saerok Shim
  • , Jihyeong Hwang
  • , Eun Seon Yoo
  • , Na Won Kim
  • , Chang Seon Song
  • , Hyunjhung Jhun
  • , Ho Young Park
  • , Youngmin Lee
  • , Kyeong Cheol Shin
  • , Sun Young Han
  • , Je Kyung Seong
  • , Yang Kyu Choi
  • , Soohyun Kim
  • Konkuk University
  • Korea Food Research Institute
  • Inje University
  • Yeungnam University
  • Gyeongsang National University
  • Seoul National University

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The SARS-CoV-2 coronavirus, which causes a respiratory disease called COVID-19, has been declared a pandemic by the World Health Organization (WHO) and is still ongoing. Vaccination is the most important strategy to end the pandemic. Several vaccines have been approved, as evidenced by the ongoing global pandemic, but the pandemic is far from over and no fully effective vaccine is yet available. One of the most critical steps in vaccine development is the selection of appropriate antigens and their proper introduction into the immune system. Therefore, in this study, we developed and evaluated two proposed vaccines composed of single and multiple SARS-CoV-2 polypeptides derived from the spike protein, namely, vaccine A and vaccine B, respectively. The polypeptides were validated by the sera of COVID-19-vaccinated individuals and/or naturally infected COVID-19 patients to shortlist the starting pool of antigens followed by in vivo vaccination to hACE2 transgenic mice. The spike multiple polypeptide vaccine (vaccine B) was more potent to reduce the pathogenesis of organs, resulting in higher protection against the SARS-CoV-2 infection.

Original languageEnglish
Article number1098461
JournalFrontiers in Immunology
Volume14
DOIs
StatePublished - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19 vaccine
  • SARS-CoV-2
  • in vivo mouse model
  • pathogenesis
  • spike polypeptide

Fingerprint

Dive into the research topics of 'COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2'. Together they form a unique fingerprint.

Cite this